We are live on ! Find out more
VCYT icon

Veracyte

111 hedge funds and large institutions have $340M invested in Veracyte in 2018 Q3 according to their latest regulatory filings, with 38 funds opening new positions, 45 increasing their positions, 16 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,800% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 2

181% more repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 16

50% more funds holding in top 10

Funds holding in top 10: 23 (+1)

48% more funds holding

Funds holding: 75111 (+36)

47% more capital invested

Capital invested by funds: $231M → $340M (+$108M)

18.04% more ownership

Funds ownership: 72.14%90.18% (+18%)

Holders
111
Holders Change
+36
Holders Change %
+48%
% of All Funds
2.54%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
38
Increased
45
Reduced
16
Closed
2
Calls
$780K
Puts
Net Calls
+$780K
Net Calls Change
+$18K
Name Holding Trade Value Shares
Change
Change in
Stake
QCMC
26
Quantum Capital Management (California)
California
$2.43M +$697K +63,246 +33%
RA
27
Royce & Associates
New York
$2.36M +$1.9M +172,150 +230%
Acadian Asset Management
28
Acadian Asset Management
Massachusetts
$2.34M +$2.24M +203,037 +485%
Victory Capital Management
29
Victory Capital Management
Texas
$2.2M +$2.54M +230,000 New
Russell Investments Group
30
Russell Investments Group
United Kingdom
$2.11M +$2.44M +221,038 New
PCM
31
Perkins Capital Management
Minnesota
$2.02M +$669K +60,700 +40%
AG
32
Algert Global
California
$2.02M +$992K +89,987 +74%
OAM
33
Oxford Asset Management
United Kingdom
$1.93M +$1.95M +177,221 +774%
TCIM
34
TIAA CREF Investment Management
New York
$1.85M +$789K +71,510 +58%
PAM
35
Panagora Asset Management
Massachusetts
$1.76M -$256K -23,238 -11%
BCM
36
Bridgeway Capital Management
Texas
$1.62M -$2.06M -186,800 -52%
TCM
37
Timpani Capital Management
Wisconsin
$1.59M +$1.84M +166,747 New
PCM
38
Prelude Capital Management
New York
$1.43M -$347K -31,465 -17%
Bank of America
39
Bank of America
North Carolina
$1.4M +$715K +64,864 +80%
California Public Employees Retirement System
40
California Public Employees Retirement System
California
$1.36M -$69.5K -6,300 -4%
Adage Capital Partners
41
Adage Capital Partners
Massachusetts
$1.19M +$1.38M +125,000 New
Charles Schwab
42
Charles Schwab
California
$1.04M -$368K -33,406 -23%
Citadel Advisors
43
Citadel Advisors
Florida
$1M +$1.16M +104,741 New
Squarepoint
44
Squarepoint
New York
$990K +$592K +53,684 +107%
GF
45
Gabelli Funds
New York
$955K +$1.1M +100,000 New
Neuberger Berman Group
46
Neuberger Berman Group
New York
$907K +$1.05M +95,000 New
EGI
47
EAM Global Investors
California
$906K +$1.05M +94,900 New
Bank of New York Mellon
48
Bank of New York Mellon
New York
$874K +$230K +20,815 +29%
OAM
49
Oberweis Asset Management
Illinois
$836K +$965K +87,500 New
SIM
50
Spark Investment Management
New York
$758K +$736K +66,700 +525%

VCYT Hedge Fund Activity: Q3 2018 in Review

111 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Veracyte (VCYT) for Q3 2018, worth a combined $340M — up 47% from $231M a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new VCYT positions and 2 closed out — a net gain of 36 holders — while 45 added to existing stakes and 16 trimmed.

The largest buyer was Versant Venture Management, opening a new position worth an estimated $39.9M. The largest seller was Acuta Capital Partners, cutting an estimated $17.3M.

  • 111 institutional investors held Veracyte (VCYT) as of Q3 2018, up from 75 in Q2 2018.
  • Funds reported $340M of Veracyte stock for Q3 2018, up 47% quarter-over-quarter.
  • 38 funds opened new Veracyte positions in Q3 2018 and 2 closed out, a net change of +36 holders.
  • The largest Veracyte buyer in Q3 2018 was Versant Venture Management, an estimated $39.9M added.
  • The largest Veracyte seller in Q3 2018 was Acuta Capital Partners, an estimated $17.3M sold.

Based on aggregated 13F filings for Q3 2018.